NO20014845L - Anvendelse av arylalkanoylpyridaziner - Google Patents
Anvendelse av arylalkanoylpyridazinerInfo
- Publication number
- NO20014845L NO20014845L NO20014845A NO20014845A NO20014845L NO 20014845 L NO20014845 L NO 20014845L NO 20014845 A NO20014845 A NO 20014845A NO 20014845 A NO20014845 A NO 20014845A NO 20014845 L NO20014845 L NO 20014845L
- Authority
- NO
- Norway
- Prior art keywords
- arylalkanoylpyridazines
- osteoporosis
- atherosclerosis
- tumors
- aids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Oppfinnelsen vedrører anvendelse av forbindelser med formel (I) d) NH-CO-B hvor R1, R2, Q og B har betydningene an- gitt i krav l, og/eller deres fysiologisk forenlige salter, til fremstilling av et medikament for behandling av osteoporose, tumorer, aterosklerose, reumatoid artritt, multippel sklerose, diabetes mellitus, ulcerøs kolitt og AIDS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19915364A DE19915364A1 (de) | 1999-04-06 | 1999-04-06 | Verwendung von Arylalkanoylpyridazinen |
PCT/EP2000/002280 WO2000059484A2 (de) | 1999-04-06 | 2000-03-15 | Verwendung von arylalkanoylpyridazinen |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014845D0 NO20014845D0 (no) | 2001-10-05 |
NO20014845L true NO20014845L (no) | 2001-10-05 |
Family
ID=7903583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014845A NO20014845L (no) | 1999-04-06 | 2001-10-05 | Anvendelse av arylalkanoylpyridaziner |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1143944A3 (no) |
JP (1) | JP2002541095A (no) |
KR (1) | KR20020000550A (no) |
CN (1) | CN1355702A (no) |
AR (1) | AR023261A1 (no) |
AU (1) | AU3811600A (no) |
BR (1) | BR0009549A (no) |
CA (1) | CA2367051A1 (no) |
CZ (1) | CZ20013598A3 (no) |
DE (1) | DE19915364A1 (no) |
HU (1) | HUP0200311A3 (no) |
ID (1) | ID30381A (no) |
MX (1) | MXPA01010034A (no) |
NO (1) | NO20014845L (no) |
PL (1) | PL350963A1 (no) |
RU (1) | RU2001129703A (no) |
WO (1) | WO2000059484A2 (no) |
ZA (1) | ZA200109120B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040087335A (ko) | 2002-03-01 | 2004-10-13 | 야마노우치세이야쿠 가부시키가이샤 | 질소 함유 복소환 화합물 |
DE10224888A1 (de) * | 2002-06-05 | 2003-12-24 | Merck Patent Gmbh | Pyridazinderivate |
DE10225574A1 (de) * | 2002-06-10 | 2003-12-18 | Merck Patent Gmbh | Aryloxime |
WO2005002590A1 (ja) * | 2003-07-01 | 2005-01-13 | Astellas Pharma Inc. | 骨量増加誘導剤 |
AR067354A1 (es) * | 2007-06-29 | 2009-10-07 | Sunesis Pharmaceuticals Inc | Compuestos utiles como inhibidores de la raf quinasa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19632549A1 (de) * | 1996-08-13 | 1998-02-19 | Merck Patent Gmbh | Arylalkanoylpyridazine |
DE19826841A1 (de) * | 1998-06-16 | 1999-12-23 | Merck Patent Gmbh | Arylalkanoylpyridazine |
DE19850701A1 (de) * | 1998-11-04 | 2000-05-11 | Merck Patent Gmbh | Benzoylpyridazine |
DE19915365A1 (de) * | 1999-04-06 | 2000-10-12 | Merck Patent Gmbh | Tetrahydropyridazin-Derivate |
-
1999
- 1999-04-06 DE DE19915364A patent/DE19915364A1/de not_active Withdrawn
-
2000
- 2000-03-15 PL PL00350963A patent/PL350963A1/xx unknown
- 2000-03-15 RU RU2001129703/15A patent/RU2001129703A/ru unknown
- 2000-03-15 AU AU38116/00A patent/AU3811600A/en not_active Abandoned
- 2000-03-15 CA CA002367051A patent/CA2367051A1/en not_active Abandoned
- 2000-03-15 EP EP00916949A patent/EP1143944A3/de not_active Withdrawn
- 2000-03-15 CN CN00805648A patent/CN1355702A/zh active Pending
- 2000-03-15 BR BR0009549-4A patent/BR0009549A/pt active Pending
- 2000-03-15 JP JP2000609048A patent/JP2002541095A/ja active Pending
- 2000-03-15 WO PCT/EP2000/002280 patent/WO2000059484A2/de not_active Application Discontinuation
- 2000-03-15 CZ CZ20013598A patent/CZ20013598A3/cs unknown
- 2000-03-15 KR KR1020017011993A patent/KR20020000550A/ko not_active Application Discontinuation
- 2000-03-15 MX MXPA01010034A patent/MXPA01010034A/es not_active Application Discontinuation
- 2000-03-15 HU HU0200311A patent/HUP0200311A3/hu unknown
- 2000-03-15 ID IDW00200102346A patent/ID30381A/id unknown
- 2000-04-05 AR ARP000101547A patent/AR023261A1/es unknown
-
2001
- 2001-10-05 NO NO20014845A patent/NO20014845L/no not_active Application Discontinuation
- 2001-11-05 ZA ZA200109120A patent/ZA200109120B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20014845D0 (no) | 2001-10-05 |
DE19915364A1 (de) | 2000-10-12 |
CA2367051A1 (en) | 2000-10-12 |
ID30381A (id) | 2001-11-29 |
HUP0200311A2 (hu) | 2002-11-28 |
WO2000059484A2 (de) | 2000-10-12 |
CN1355702A (zh) | 2002-06-26 |
ZA200109120B (en) | 2003-11-13 |
EP1143944A2 (de) | 2001-10-17 |
MXPA01010034A (es) | 2002-04-24 |
JP2002541095A (ja) | 2002-12-03 |
RU2001129703A (ru) | 2004-02-20 |
HUP0200311A3 (en) | 2002-12-28 |
AU3811600A (en) | 2000-10-23 |
AR023261A1 (es) | 2002-09-04 |
CZ20013598A3 (cs) | 2002-01-16 |
BR0009549A (pt) | 2002-03-26 |
EP1143944A3 (de) | 2002-09-11 |
PL350963A1 (en) | 2003-02-24 |
KR20020000550A (ko) | 2002-01-05 |
WO2000059484A3 (de) | 2001-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0124627D0 (en) | Novel compounds | |
ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
NO20065178L (no) | Tienopyridinderivater | |
MXPA05009969A (es) | Metodo para aislar la forma cristalina i de la 5-azacitidina. | |
WO2003006425A3 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
WO2004035569A3 (de) | Neue verbindungen mit antibakterieller aktivität | |
NO20005715L (no) | Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20060142L (no) | Syklisk tertiaer aminforbindelse | |
HK1088013A1 (en) | Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs | |
GB9903670D0 (en) | Liquid crystal compounds | |
NO20076145L (no) | Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav | |
DK1831239T3 (da) | Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde | |
BR9206823A (pt) | Preparação de piperidinas substituídas | |
MXPA03009602A (es) | Analogos de nociceptina. | |
DK0503453T3 (da) | Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde | |
NO20014845L (no) | Anvendelse av arylalkanoylpyridaziner | |
NO20060258L (no) | Nematicidale tiazolin-inneholdende fluorobutener | |
WO2002079753A3 (en) | 2-aminobenzoxazole derivatives and combinatorial libraries thereof | |
TW200619250A (en) | Resin composition and resin sheet for optical use, and optical semiconductor device | |
GB0327323D0 (en) | Novel pharmaceuticals | |
NO20052197L (no) | Fremgangsmate for fremstilling av pyrazol | |
DK1598358T3 (da) | Forbindelser indeholdende 3,4-methylendioxythiophen-enheder | |
WO2000043375A3 (de) | Substituierte arylheterocyclen | |
TW200712182A (en) | Ferroelectric liquid crystal compound | |
CA2394611A1 (en) | Process for the preparation of 1,3-disubstituted 2-nitroguanidines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |